Trial Profile
ART Drug Dosage Adjustment Using FSCII in Chinese HIV-infected Population
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Lamivudine (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 18 Jan 2017 Status changed from active, no longer recruiting to completed.
- 12 Oct 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Dec 2016.
- 12 Oct 2016 Status changed from recruiting to active, no longer recruiting.